July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages WEBTOON Entertainment Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBTN
October 06, 2024 19:11 ET | The Rosen Law Firm PA
NEW YORK, Oct. 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of WEBTOON Entertainment Inc. (NASDAQ: WBTN) pursuant...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Terran Orbital Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LLAP
October 06, 2024 15:33 ET | The Rosen Law Firm PA
NEW YORK, Oct. 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Terran...
CoinSharesLogo_Black_RGB.png
CoinShares Announces Exercise of Employee Incentive Plan Options
September 11, 2024 12:44 ET | CoinShares International Limited
11 September 2024 | SAINT HELIER, Jersey | CoinShares International Limited (“CoinShares'' or “the Company”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF). On 11 September 2024, a total of 55,720...
Full Logo - OKYO .jpg
OKYO Pharma Announces Chairman Acquires Shares
September 10, 2024 07:00 ET | OKYO Pharma LTD
LONDON and NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Full Logo - OKYO .jpg
OKYO Pharma Announces Chairman Acquires Shares
September 05, 2024 07:00 ET | OKYO Pharma LTD
LONDON and NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Full Logo - OKYO .jpg
OKYO Pharma Announces Chairman Acquires Shares
August 23, 2024 07:00 ET | OKYO Pharma LTD
LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Full Logo - OKYO .jpg
OKYO Pharma Announces Chairman Acquires Shares
August 21, 2024 07:00 ET | OKYO Pharma LTD
LONDON and NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Tevogen Logo Notified.png
Tevogen Bio’s Founding CEO, Ryan Saadi, Expresses Conviction in Company’s Growth Strategy and Reaffirms Newly Effective Form S-1 Does Not Relate to Previously Undisclosed New Issuance of Dilutive Securities
August 09, 2024 11:00 ET | Tevogen Bio Inc
Tevogen Bio reaffirms that the registration statement does not relate to any previously undisclosed new issuances of dilutive securities.
July 30, 2021 - ROSEN LOGO.jpg
DOCS INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
May 23, 2024 17:23 ET | The Rosen Law Firm PA
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022 and...
multitude_logo_01.png
Multitude SE: The Board of Directors of Multitude SE has decided to start a share buyback programme
May 16, 2024 01:30 ET | Multitude SE
Multitude SE: The Board of Directors of Multitude SE has decided to start a share buyback programme Helsinki, 16 May 2024 – The Board of Directors of Multitude SE, a listed European FinTech company,...